Xenon Pharmaceuticals, Inc.
(NASDAQ : XENE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -2.10%68.060.0%$2168.10m
NVAXNovavax, Inc. 12.25%139.6696.5%$1152.54m
SRNESorrento Therapeutics, Inc. 12.65%13.981.5%$823.71m
GILDGilead Sciences, Inc. -0.74%68.331.0%$567.18m
AMGNAmgen, Inc. -0.59%240.301.3%$482.28m
REGNRegeneron Pharmaceuticals, Inc. -0.41%609.832.7%$397.55m
VRTXVertex Pharmaceuticals, Inc. -0.48%269.541.9%$365.65m
BIIBBiogen, Inc. -0.27%292.441.6%$354.60m
BNTXBioNTech SE 0.20%69.250.0%$351.57m
ILMNIllumina, Inc. 0.75%346.733.5%$340.87m
VXRTVaxart, Inc. 2.72%9.450.0%$269.66m
ATNMActinium Pharmaceuticals, Inc. 0.63%9.6113.3%$231.63m
EBSEmergent BioSolutions, Inc. 3.07%133.556.4%$193.86m
ALXNAlexion Pharmaceuticals, Inc. -0.27%102.502.0%$167.39m
SGENSeattle Genetics, Inc. 0.52%159.626.0%$159.55m

Company Profile

Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.